International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new‐onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT‐HF (International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure) is a global, prospective, and observational study designed to characterize patient trajectories longitudinally during and following an index hospitalization for HF.

[1]  Jiang Lixin,et al.  Outline of the report on cardiovascular diseases in China, 2014. , 2016, European heart journal supplements : journal of the European Society of Cardiology.

[2]  M. Vaduganathan,et al.  Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. , 2014, American heart journal.

[3]  Mark Woodward,et al.  Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis , 2014, PLoS medicine.

[4]  P. Ponikowski,et al.  International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial , 2014, European journal of heart failure.

[5]  C. O'connor,et al.  Lessons from the TOPCAT trial. , 2014, The New England journal of medicine.

[6]  Sanjiv J Shah,et al.  Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.

[7]  Naoki Sato,et al.  The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.

[8]  G. Filippatos,et al.  Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology-Heart Failure pilot survey. , 2014, European heart journal. Acute cardiovascular care.

[9]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[10]  P. Ponikowski,et al.  Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry , 2013, European journal of heart failure.

[11]  Hiroaki Shimokawa,et al.  Epidemiology of heart failure in Asia. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[12]  W. Shimizu,et al.  Asian Sudden Cardiac Death in Heart Failure (ASIAN‐HF) registry , 2013, European journal of heart failure.

[13]  A. Strömberg,et al.  The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity , 2013, Health and Quality of Life Outcomes.

[14]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[15]  K. Sliwa,et al.  The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. , 2012, Archives of internal medicine.

[16]  Adrian F Hernandez,et al.  Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes , 2012, Circulation.

[17]  Sheng-Shou Hu,et al.  Outline of the report on cardiovascular disease in China, 2010. , 2012, Biomedical and environmental sciences : BES.

[18]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[19]  Wan Azman Wan Ahmad,et al.  Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). , 2012, Journal of cardiac failure.

[20]  V. Roger,et al.  Population health, outcomes research, and prevention: example of the American Heart Association 2020 goals. , 2012, Circulation. Cardiovascular quality and outcomes.

[21]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[22]  L. Mimish,et al.  Design and preliminary results of the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure † , 2011, European journal of heart failure.

[23]  R. Porcher,et al.  Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) , 2011, Intensive Care Medicine.

[24]  P. Ponikowski,et al.  EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) , 2010, European journal of heart failure.

[25]  Mark D. Huffman,et al.  Heart failure: epidemiology and prevention in India. , 2010, The National medical journal of India.

[26]  M. Kawana,et al.  Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. , 2010, American heart journal.

[27]  K. Swedberg,et al.  Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. , 2008, Journal of the American College of Cardiology.

[28]  Masahiro Ito,et al.  Impending epidemic: future projection of heart failure in Japan to the year 2055. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[29]  Nancy M Albert,et al.  Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. , 2006, JAMA.

[30]  P. Ponikowski,et al.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.

[31]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[32]  M. C. Reilly,et al.  The validity and accuracy of the Work Productivity and Activity Impairment questionnaire – irritable bowel syndrome version (WPAI:IBS) , 2004, Alimentary pharmacology & therapeutics.

[33]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[34]  P. Venugopalan,et al.  Prevalence and aetiology of heart failure in an Arab population , 2001, European journal of heart failure.

[35]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[36]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[37]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.